SCHEMBL4063126

SCHEMBL4063126

Cc1cc(Cc2cc(Cc3cc(C)c(O)cc3C)c(O)c(Cc3cc(C)c(O)cc3C)c2)c(C)cc1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SHBG P04278 1/20 0.48
AMY1A P0DUB6 1/20 0.43
CYP2C9 P11712 4/20 0.41
CYP2C19 P33261 4/20 0.41
HIF1A Q16665 4/20 0.41
CYP2D6 P10635 2/20 0.41
HSD17B10 Q99714 2/20 0.41
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 1/20 0.40
G6PD P11413 1/20 0.40
PKM P14618 1/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
ALOX12 P18054 1/20 0.40
MAPK1 P28482 1/20 0.40
CCR6 P51684 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL278228 0.93 DHFR (0.43) SHBGAMY1ACYP2C9CYP2C19HIF1A
SCHEMBL30375057 0.93 SHBG (0.59) SHBGAMY1ACYP2C9CYP2C19HIF1A
SCHEMBL278742 0.93 SHBG (0.59) SHBGAMY1ACYP2C9CYP2C19HIF1A
SCHEMBL8819971 0.90 SHBG (0.53) SHBGAMY1ACYP2C9CYP2C19HIF1A
SCHEMBL278357 0.89 SHBG (0.65) SHBGAMY1ACYP2C9CYP2C19HIF1A
SCHEMBL22500451 0.89 HSPA5 (0.50) SHBGAMY1ACYP2C9CYP2C19HIF1A
SCHEMBL278491 0.86 AMY1A (0.58) SHBGAMY1ACYP2C9CYP2C19HIF1A
SCHEMBL30375265 0.86 AMY1A (0.58) SHBGAMY1ACYP2C9CYP2C19HIF1A
SCHEMBL29941774 0.86 AMY1A (0.58) SHBGAMY1ACYP2C9CYP2C19HIF1A
SCHEMBL13609020 0.86 AMY1A (0.58) SHBGAMY1ACYP2C9CYP2C19HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7534547-B2 Optically active compound and photosensitive resin composition OSAKA GAS COMPANY LIMITED (JP) 2009-05-19 US disclosed
EP-1375463-A1 OPTICALLY ACTIVE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION Kansai Research Institute, Inc. (JP) 2004-01-02 EP disclosed
US-20030211421-A1 Optically active compound and photosensitive resin composition KRI, INC. (JP) 2003-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030211421-A1 Optically active compound and photosensitive resin composition ARCN1, RAD51, PAM SHBG 3960/4885AMY1A 2387/4885CYP2C9 1479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.